Mark B. Taubman, M.D.

Education/Certification

M.D. 1978
New York University School of Medicine, New York, NY

1979-81
Residency, Brigham & Women’s Hospital, Boston, MA

1981-84
Cardiology Fellow, Brigham & Women’s Hospital, Boston, MA

1984-89
Research Fellow in Cardiology, Boston Children’s Hospital, Boston, MA

Research and Professional Experience

Dr. Taubman joined the Cardiology Unit as Unit Chief in February 2003. Dr. Taubman is an international authority in vascular biology with research interests in tissue factor biology and chemokines. He is also the Director of the Center for Cellular and Molecular Cardiology (CCMC), which is located in the recent extension of the Medical Research Building.

References:

1. Pawlinski, R., Fernandez, A., Kehrle, B., Pedersen, B., Parry, G., Erlich, J., Pyo, R., Gutstein, D., Zhang, J., Melis, E., Carmeliet, P., Baretton, G., Luther, T., Taubman, M.B., Rosen E., and Mackman, N. Tissue factor deficiency causes cardiac fibrosis and left ventricular dysfunction. In Press, Proc Natl Acad Sci, USA.

2. Rong, J.X., Berman, J.W., Taubman, M.B., and Fisher, E.A. Lysophosphatidylcholine stimulates monocyte chemoattractant protein-1 gene expression in rat aortic smooth muscle cells. Arterioscler Thromb Vasc Biol, 2002; 22:1617-1623.

3. Lieb, M.E., Menzies, K., Moschella, M.C., Ni, R., and Taubman, M.B. The mammalian EGLN genes have distinct patterns of mRNA expression and regulation. Biochem Cell Biol. 2002; 80:421-426.

4. Roque, M., Kim, W.J.J., Gazdiou, M., Malik, A., Reis, E.D., Fallon, J.T., Badimon, J.J., Charo, I.F., and Taubman, M.B. CCR2 deficiency decreases intimal hyperplasia after arterial injury. Arterioscler, Thromb, Vasc Biol. 2002; 22:554-559.

5. Schecter, A.D., Berman, A.B., Yi, L., Mosoian, A., Klotman, M.E., and Taubman, M.B. Human immunodeficiency virus envelope gp120 activates human arterial smooth muscle cells. Proc Natl Acad Sci, USA. 2001; 98:10142-10147.